Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
01/1999
01/27/1999EP0893501A2 Ferrichrome transport atp-binding protein
01/27/1999EP0893500A2 BmrU gene from Staphylococcus aureus
01/27/1999EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus
01/27/1999EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
01/27/1999EP0893496A2 Histidyl tRNA synthetase from Chlamydia trachomatis
01/27/1999EP0893495A2 Isoleucyl tRNA synthetase from Chlamydia trachomatis
01/27/1999EP0893494A2 Aspartyl tRNA synthetase from Chlamydia trachomatis
01/27/1999EP0893450A1 Chromatographic method for high yield purification and viral inactivation of antibodies
01/27/1999EP0892854A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto
01/27/1999EP0892809A1 Fhit proteins and nucleic acids and methods based thereon
01/27/1999EP0892643A1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith
01/27/1999EP0778777A4 A method of sequencing proteins by epitope ordering and protein restriction mapping
01/27/1999EP0554441B1 Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy
01/27/1999EP0542770B1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
01/27/1999EP0461177B1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
01/27/1999CN1206350A Hybrid with interferon-'alpha' and immunoglobulin Fc linkes through non-immunogenic peptide
01/26/1999US5864027 HIV envelope polypeptides
01/26/1999US5864020 A monoclonal antibody specifically binds to a hepatoma transmembrane kinase receptor ligand having selective amino acid sequence
01/26/1999US5864019 Antigen-binding protein comprising: 3 or 4 vh domains; spacing polypeptide attached to c-terminal end of each vh domain; linkage polypeptide containing linkable residues attached to c-terminal end of each spacing polypeptide; vl domain
01/26/1999US5864018 Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor
01/26/1999US5864015 Hodgkin's disease associated molecules
01/26/1999US5864011 Cancer related antigen
01/26/1999US5863890 Smooth muscle relaxants; anticoagulants; vasodilation; protein regulation; cellular metabolism; blood oxygen transport
01/26/1999US5863804 Monoclonal or polyclonal antibodies obtained by administering to an animal a synthetic peptide or a recombinant protein fragment having a partial sequence of t-cadherin, isolating from animal's serum
01/26/1999US5863795 Nucleic acids that encode peptides which modulate apoptosis
01/26/1999US5863780 A polynucleotide sequence encodes human protein kinase polypeptide; culture product
01/26/1999US5863779 UBC7-like ubiquitin-conjugating enzyme
01/26/1999US5863777 DNA encoding alanyl tRNA synthetase from streptococcus pneumonine
01/26/1999US5863770 Stable meterologous propagation of CFTR protein variant cDNA
01/26/1999US5863769 DNA encoding interleukin-1 receptor antagonist (IL-1raβ)
01/26/1999US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders.
01/26/1999US5863765 Connecting nucleotide sequences, transformation, cultures and cleavage of peptide sites
01/26/1999US5863757 An expression vector comprising polynucleotide having an open reading frame operably linked to a promoter and encoding a specific polypeptide
01/26/1999US5863755 Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-κ
01/26/1999US5863745 Contacting cells targeted to be killed with a cytotoxic amount of an antibody-pe40 recombinant fusion protein, wherein said antibody is a single-chain fv fragment (scfv) and said pe40 is a pseudomonas exotoxin fragment
01/26/1999US5863744 Monoclonal antibody specific for an epitope of rr/b; amino acid sequences
01/26/1999US5863739 Assay and kit for the detection of α platelet derived growth factor receptor
01/26/1999US5863735 Human transmembrane 4 superfamily protein
01/26/1999US5863724 Methods of screening for persistent hyperinsulinemic hypoglycemia of infancy
01/26/1999US5863719 Methods for detecting hepatitis C virus using polynucleotides specific for same
01/26/1999US5863718 Small peptides which inhibit to T-4 receptors and act as immunogens
01/26/1999US5863540 Suppressing t-cell activation, inhibiting cd44-mediated cell adhesion and cd44-monocyte il1 release, antiinflammation, -carcinogenic and -metastasis agents; transporting a drug to a site of inflammation
01/26/1999US5863538 Compositions for targeting the vasculature of solid tumors
01/26/1999US5863537 Polypeptide comprising a variable region having the amino acid sequence of the variable region selected from the group consisting of h25d2h-1, h25d2h-2, h25d2h-3, h25d2h-4 and h25d2h-5
01/26/1999US5863535 Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β)
01/26/1999CA2137639C Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivate thereof having anti-tumor activity and use thereof in the therapy of malignant diseases
01/26/1999CA2005291C Feline infectious peritonitis virus diagnostic tools
01/26/1999CA2002862C Cloning and expression of a protein which modulates cellular response to type i interferon
01/26/1999CA1340350C Monoclonal antibody to the 75 kd subunit of the human interleukin-2 receptor and use thereof
01/26/1999CA1340329C Superoxide dismutasee
01/26/1999CA1340328C Method for protein binding enzyme complementation assays
01/25/1999CA2238664A1 Novel regulator
01/25/1999CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor
01/24/1999CA2238658A1 Novel grea
01/23/1999CA2238682A1 Novel asps
01/23/1999CA2238679A1 Novel phes
01/23/1999CA2238677A1 Novel iles
01/23/1999CA2238674A1 Novel tetracycline resistance protein
01/23/1999CA2238671A1 Novel bmru
01/23/1999CA2238667A1 Novel ferrichrome transport atp-binding protein
01/23/1999CA2238665A1 Novel reductase
01/23/1999CA2238663A1 Novel hiss
01/23/1999CA2238611A1 Novel lyss
01/23/1999CA2238608A1 Novel cyss
01/21/1999WO1999002991A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application
01/21/1999WO1999002734A1 Reagents and methods useful for detecting diseases of the urinary tract
01/21/1999WO1999002721A1 THE ESCHERICHIA COLI csrB GENE, RNA ENCODED THEREBY, AND METHODS OF USE THEREOF
01/21/1999WO1999002713A1 Pseudomonas exotoxin a-like chimeric immunogens
01/21/1999WO1999002712A1 Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune response
01/21/1999WO1999002707A1 Fusion proteins comprising coiled-coil structures
01/21/1999WO1999002686A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof
01/21/1999WO1999002681A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof
01/21/1999WO1999002680A1 New human growth regulator protein
01/21/1999WO1999002679A1 Frazzled nucleotide sequences, expression products, compositions and uses
01/21/1999WO1999002678A1 Wa545 compositions
01/21/1999WO1999002661A2 Iron reductase
01/21/1999WO1999002654A1 Isolation of bone and cartilage precursor cells
01/21/1999WO1999002567A2 Compositions and methods for producing homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells
01/21/1999WO1999002565A2 Agent for the treatment and/or prophylaxis of microcirculation disorders
01/21/1999WO1999002564A2 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same
01/21/1999WO1999002563A1 Ligand for herpes simplex virus entry mediator and methods of use
01/21/1999WO1999002562A1 Isolated dendritic cell membrane protein genes
01/21/1999WO1999002561A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation
01/21/1999WO1999002559A1 Reagents and methods useful for detecting diseases of the breast
01/21/1999WO1999002556A1 Semaphorin receptors
01/21/1999WO1999002553A1 Serum immunoregulatory polypeptides and uses therefor
01/21/1999WO1999002550A1 Ctl epitopes from ebv
01/21/1999WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
01/21/1999WO1999002545A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
01/21/1999WO1999002188A1 Hen egg yolk antibodies to clostridium difficile antigens and use in therapy for pseudomembranous colitis
01/21/1999WO1999002187A2 Decreased fat absorption with an anti-lipase antibody
01/21/1999WO1999002185A1 Methods and compositions for impairing multiplication of hiv-1
01/21/1999WO1999002184A1 Causative agent of sow abortion and mortality syndrome (sams), vaccine compositions, antibodies and method
01/21/1999WO1998047922A3 Determination of recombinant glycosylated proteins and peptides in biological fluids
01/21/1999WO1998031389A3 Fibronectin binding protein compositions, antibodies thereto, and methods of use
01/21/1999WO1998024810A3 Vertebrate homologues of unc-53 protein of c. elegans
01/21/1999CA2715850A1 Isolated dendritic cell membrane protein genes
01/21/1999CA2295914A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application
01/21/1999CA2295908A1 New human growth regulator protein
01/21/1999CA2295735A1 Decreased fat absorption with an anti-lipase antibody